Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cell Death & Disease|March 4, 2011
The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(-) subsetC Zhao, Y-C Tan, W-C Wong, et al.
Zhonghua Yi Xue Za Zhi|September 15, 2025
[Improved detection methods and sequence characteristics of PML::RARA variant transcripts in patients with acute promyelocytic leukemia]X L Ma, F Wang, X Chen, et al.
The Medical Journal of Malaysia|January 30, 2023
Prevalence of COVID-19 among healthcare workers in the paediatric department: Estimates from a multicenter cross-sectional survey in Negeri SembilanN C E David, H Juliana, M Chok, et al.
British Journal of Cancer|March 6, 2015
Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patientsS Q Wong, A Fellowes, K Doig, et al.
Zhonghua Yi Xue Za Zhi|May 8, 2026
[Transcript distribution, sequence characteristics and clinical outcomes of rare transcript types of BCR::ABL1 fusion gene-positive leukemia patients]F Wang, X L Ma, X Chen, et al.
BMC Medical Genomics|June 3, 2014
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencingStephen Q Wong, Jason Li, Angela Y-C Tan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varicesNik S Ding, Tin Nguyen, David M Iser, et al.
Leukemia|August 24, 2011
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic propertiesK C Goh, V Novotny-Diermayr, S Hart, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 12, 2017
Validation of Serial Alberta Stroke Program Early CT Score as an Outcome Predictor in Thrombolyzed Stroke PatientsWan-Yee Kong, Benjamin Y Q Tan, Nicholas J H Ngiam, et al.
Leukemia|June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignanciesS Hart, K C Goh, V Novotny-Diermayr, et al.
Pageof 5